logo
Login
Open Account
Open Demat

Sector: Pharmaceuticals & Biotechnology

|

Large Cap

Divi's Laboratories Share Price

Divi's Laboratories Ltd.

₹6,258.50

-32.50(-0.52%)

Invest in DIVISLAB with up to 2.86x margin.

Trade with MTF
23rd Feb 2026 | 3:28 PM
NSE : DIVISLAB
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Divi's Laboratories Performance

Price Movement

₹6258.50

₹6245.50

₹6343.50

↘ Today's Low↗ Today's High

1 Year Performance

₹6258.50

₹4955.00

₹7071.50

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹6,343.50
Low₹6,245.50
Open at₹6,337.00
Prev Close₹6,291.00
Volumes97.28 K
Avg Price₹6,294.79
Lower Circuit₹5,662.00
Upper Circuit₹6,920.00

Historical Performance

3M High₹6,793.00
3M Low₹5,890.00
1 Yr High₹7,071.50
1 Yr Low₹4,955.00
3 Yr High₹7,071.50
3 Yr Low₹2,730.00
5 Yr High₹7,071.50
5 Yr Low₹2,730.00

Divi's Laboratories Fundamentals

Market Cap
Market Runner Up
1,67,072.70 Cr.
PE Ratio (TTM)
High in industry
67.40
Dividend Yield
Below industry Median
0.50
Net Profit TTM
19.9% incr over last year
2,479
Net Profit Growth
19.9% incr over last year
2,479
PEG Ratio
High in industry
3.40
ROE
24.2% incr over last year
14.63
Operating Revenue TTM
10,314
Operating Revenue Growth
13.6% incr over last year
Book Value
High in industry
10.80
MFI
MFI is mid-range
45.78
RSI
RSI is mid-range
54
EPS (TTM)
82.53
Debt to Equity
0
Face Value
2
Operating Profit Margin Qtr.
30.56
Operating Profit Qtr.
890
Net Profit Qtr.
583
Operating Revenue Qtr.
2,604
PB Ratio
10.80

Divi's Laboratories Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Total Revenue2,5782,6602,3572,5362,297
Operating Expense1,6711,7651,6141,6551,550
Operating Profit907895743881747
Depreciation11611311210799
Interest68300
Tax200224190194136
Net Profit598696557667594

DIVISLAB Stock Recommendation by HDFC

View Call ↗

Research Type

Equity , Long Term

Buy Range

₹6,363 - ₹0

Target Price

₹7,630

Stop Loss

-

Target Date

7 Jan 27

Potential Returns

19.91 %

View Call ↗

Divi's Laboratories Technicals

Divi's Laboratories Ltd. EMA & SMA

₹6258.50

-32.50 (-0.52%)

↗ Bullish Moving Average

12

↘ Bearish Moving Average

4

Day EMA5 ₹6270.1
Day EMA10 ₹6235.9
Day EMA12 ₹6226.5
Day EMA20 ₹6212.7
Day EMA26 ₹6217
Day EMA50 ₹6256.4
Day EMA100 ₹6294.5
Day EMA200 ₹6226.4

Divi's Laboratories Support and Resistance

Resistance

First Resistance₹6342.83
Second Resistance₹6392.17
Third Resistance₹6440.83

Support

First Support₹6244.83
Second Support₹6196.17
Third Support₹6146.83

Technical Indicators

Day RSI54.00
Day MFI45.78
Day ADX24.56
Day Commodity Channel Index93.30
William-58.28
Day MACD9.47
Day MACD Signal Line-19.22
Day ATR175.09
Day ROC1252.31
Day ROC214.69

Divi's Laboratories Shareholding Pattern

Held BySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoter51.951.951.951.951.951.9
FII17.2181819.719.420.1
DII21.120.520.719.119.819.3
Public9.89.69.49.398.8

Divi's Laboratories Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day3.04 L3.92 L77.65%
Week1.72 L2.84 L60.48%
1 Month2.34 L4.26 L54.87%
6 Month2.29 L4 L57.19%

Divi's Laboratories SWOT Analysis

Strengths12
Weakness9
Opportunity2
Threats1

Benjamin Graham Value Screen

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Expensive Performers (DVM)

Annual Profit Growth higher than Sector Profit Growth

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Companies with Low Debt

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

MACD crossed above zero line previous end of day

Divi's Laboratories Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
25 Jul, 202530FINAL25 Jul, 2025Equity Share
02 Aug, 202430FINAL02 Aug, 2024Equity Share
11 Aug, 202330FINAL11 Aug, 2023Equity Share
11 Aug, 202230FINAL12 Aug, 2022Equity Share
17 Aug, 202120FINALEquity Share
25 Feb, 202016INTERIM26 Feb, 2020Equity Share
14 Aug, 201916FINALEquity Share
31 Aug, 201810FINALEquity Share
15 Sep, 201710FINALEquity Share
17 Mar, 201610INTERIM18 Mar, 2016Equity Share

Divi's Laboratories Stock Comparison

Financials
Anthem Biosciences Ltd.
Emcure Pharmaceuticals Ltd.
Mankind Pharma Ltd.
Piramal Pharma Ltd.
Gland Pharma Ltd.
Laurus Labs Ltd.
Price (₹)₹696.90₹1,431.80₹2,045₹162₹1,803₹1,014.60
% Change2.20%-0.42%1.02%0.92%-1.03%-0.43%
Revenue TTM (₹ Cr)₹1,996.59₹8,850.08₹13,914.08₹8,871.37₹6,112.77₹6,721.63
Net Profit TTM (₹ Cr)₹484.66₹869.92₹1,779.35₹-163.61₹847.18₹843.32
PE TTM80.7031.3047.50-131.7035.1065.10
1 Year Return22.1744.17-12.08-22.4418.0995.04
ROCE26.8820.8013.276.4011.4311.82

Similar Stocks

ALKEM

Alkem Laboratories Ltd.

₹ 5487.00

+1.76%

BIOCON

Biocon Ltd.

₹ 388.00

+1.05%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 2975.00

+1.21%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 905.30

-

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2033.00

-0.50%

WOCKPHARMA

Wockhardt Ltd.

₹ 1370.00

-0.84%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1148.70

-0.87%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1732.00

+0.44%

IPCALAB

Ipca Laboratories Ltd.

₹ 1469.70

+1.37%

JBCHEPHARM

J B Chemicals & Pharmaceuticals Ltd.

₹ 2051.00

+2.53%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 8807.00

-0.93%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2635.30

+1.48%

PFIZER

Pfizer Ltd.

₹ 5066.60

+2.74%

ABBOTINDIA

Abbott India Ltd.

₹ 26425.00

+0.49%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4318.50

+1.81%

LUPIN

Lupin Ltd.

₹ 2241.00

+0.97%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1305.10

+1.93%

CIPLA

Cipla Ltd.

₹ 1327.00

-1.05%

FAQ's on DIVISLAB

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy